Total Payments
$12,660
2023 Payments
$376.38
Companies
38
Transactions
914
Medicare Patients
1,310
Medicare Billing
$187,609
Payment Breakdown by Category
Food & Beverage$12,455 (98.4%)
Education$205.54 (1.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,455 | 895 | 98.4% |
| Education | $205.54 | 19 | 1.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,233 | 206 | $0 (2023) |
| GlaxoSmithKline, LLC. | $1,133 | 81 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,086 | 86 | $0 (2023) |
| PFIZER INC. | $991.44 | 75 | $0 (2022) |
| Novartis Pharmaceuticals Corporation | $851.67 | 49 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $820.96 | 44 | $0 (2023) |
| Janssen Pharmaceuticals, Inc | $709.80 | 47 | $0 (2022) |
| Merck Sharp & Dohme LLC | $651.74 | 51 | $0 (2022) |
| Amgen Inc. | $604.57 | 40 | $0 (2023) |
| Amarin Pharma Inc. | $562.97 | 40 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $376.38 | 21 | Novo Nordisk Inc ($110.98) |
| 2022 | $2,113 | 136 | Novo Nordisk Inc ($522.61) |
| 2021 | $2,393 | 163 | Novo Nordisk Inc ($477.60) |
| 2020 | $1,661 | 120 | Novo Nordisk Inc ($314.63) |
| 2019 | $1,520 | 125 | Novo Nordisk Inc ($323.97) |
| 2018 | $2,165 | 159 | Novartis Pharmaceuticals Corporation ($317.05) |
| 2017 | $2,431 | 190 | Boehringer Ingelheim Pharmaceuticals, Inc. ($301.76) |
All Payment Transactions
914 individual payment records from CMS Open Payments — Page 1 of 37
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/04/2023 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $16.43 | General |
| Category: Cardiology | ||||||
| 04/05/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $17.50 | General |
| Category: Gastroenterology | ||||||
| 03/01/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/27/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.97 | General |
| 02/23/2023 | Lilly USA, LLC | TRULICITY (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $18.70 | General |
| Category: Diabetes | ||||||
| 02/21/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.72 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/16/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $15.54 | General |
| Category: Inflammation | ||||||
| 02/15/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $20.41 | General |
| 02/14/2023 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $14.20 | General |
| Category: Obesity | ||||||
| 02/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: RESPIRATORY | ||||||
| 02/08/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: DIABETES | ||||||
| 02/07/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/06/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.49 | General |
| Category: RESPIRATORY | ||||||
| 02/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/01/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $22.55 | General |
| Category: Obesity | ||||||
| 01/30/2023 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.58 | General |
| 01/25/2023 | Novo Nordisk Inc | Saxenda (Drug), Wegovy | Food and Beverage | In-kind items and services | $13.27 | General |
| Category: Obesity | ||||||
| 01/24/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: RESPIRATORY | ||||||
| 01/18/2023 | Astellas Pharma US Inc | Myrbetriq (Drug) | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Urology | ||||||
| 12/14/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.28 | General |
| Category: DIABETES | ||||||
| 12/12/2022 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $18.24 | General |
| Category: Bone Health | ||||||
| 12/08/2022 | Novo Nordisk Inc | Wegovy (Drug), Saxenda | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: Obesity | ||||||
| 12/06/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 73 | 84 | $30,744 | $3,746 |
| 2022 | 11 | 415 | 822 | $288,473 | $74,419 |
| 2021 | 11 | 401 | 717 | $254,049 | $63,338 |
| 2020 | 11 | 421 | 690 | $179,344 | $46,106 |
Total Patients
1,310
Total Services
2,313
Medicare Billing
$187,609
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 73 | 84 | $30,744 | $3,746 | 12.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 159 | 551 | $202,182 | $47,578 | 23.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 76 | 76 | $29,224 | $9,794 | 33.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 15 | 18 | $14,684 | $3,935 | 26.8% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 12 | 12 | $10,212 | $3,337 | 32.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 21 | 24 | $12,717 | $3,278 | 25.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 40 | 41 | $8,023 | $2,807 | 35.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 42 | 44 | $2,200 | $1,246 | 56.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 15 | 19 | $4,929 | $1,155 | 23.4% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2022 | 11 | 12 | $1,852 | $468.36 | 25.3% |
| 0054A | Adm sarscv2 30mcg trs-sucr b | Office | 2022 | 11 | 12 | $1,800 | $452.08 | 25.1% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 13 | 13 | $650.00 | $368.35 | 56.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 152 | 458 | $169,460 | $38,732 | 22.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 77 | 77 | $29,183 | $10,105 | 34.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 26 | 31 | $16,058 | $4,151 | 25.9% |
| 99496 | Transitional care management services, highly complexity, requiring face-to-face visits within 7 days of discharge | Office | 2021 | 12 | 12 | $9,612 | $2,650 | 27.6% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 17 | 17 | $10,761 | $2,343 | 21.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 28 | 28 | $5,124 | $1,823 | 35.6% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2021 | 13 | 17 | $4,454 | $1,038 | 23.3% |
| 0003A | Fee covid-19 vac 1 booster | Office | 2021 | 19 | 19 | $2,850 | $731.50 | 25.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 11 | 11 | $2,871 | $664.14 | 23.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 34 | 34 | $1,700 | $557.48 | 32.8% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2021 | 12 | 13 | $1,976 | $543.14 | 27.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 142 | 368 | $108,192 | $24,617 | 22.8% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2020 | 45 | 45 | $15,435 | $5,158 | 33.4% |
About Dr. Mohan Patel, MD
Dr. Mohan Patel, MD is a Geriatric Medicine healthcare provider based in Vandergrift, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/23/2005. The National Provider Identifier (NPI) number assigned to this provider is 1538152863.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohan Patel, MD has received a total of $12,660 in payments from pharmaceutical and medical device companies, with $376.38 received in 2023. These payments were reported across 914 transactions from 38 companies. The most common payment nature is "Food and Beverage" ($12,455).
As a Medicare-enrolled provider, Patel has provided services to 1,310 Medicare beneficiaries, totaling 2,313 services with total Medicare billing of $187,609. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Internal Medicine
- Location Vandergrift, PA
- Active Since 08/23/2005
- Last Updated 10/12/2020
- Taxonomy Code 207RG0300X
- Entity Type Individual
- NPI Number 1538152863
Products in Payments
- Ozempic (Drug) $1,026
- ENTRESTO (Drug) $774.07
- TRELEGY ELLIPTA (Drug) $648.88
- XARELTO (Drug) $621.89
- Vascepa (Drug) $562.97
- JANUVIA (Drug) $447.40
- JARDIANCE (Drug) $357.64
- CHANTIX (Drug) $298.42
- TRADJENTA (Drug) $285.05
- FARXIGA (Drug) $285.02
- Victoza (Drug) $276.15
- Saxenda (Drug) $271.49
- XIFAXAN (Drug) $249.16
- Livalo (Drug) $239.08
- ELIQUIS (Drug) $229.95
- TRULICITY (Drug) $222.76
- EVENITY (Biological) $218.74
- LYRICA (Drug) $216.70
- SPIRIVA RESPIMAT (Drug) $216.28
- BREZTRI (Drug) $214.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.